Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases.

Molecules · 2022 · PMC9031877 · PMID 35458666

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an important trendno p-value reported

Combination Therapy Combination therapy is an important trend in the development of platinum anticancer agents and for bypassing of resistance to Cisplatin derivatives [ 55 ].

also in 1,052 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.